Mohammed Bin Rashid University of Medicine and Health Sciences
United Arab Emirates
His primary areas of investigation include Immunology, Mucin, Alcoholic liver disease, Liver disease and Internal medicine. His research in Immunology intersects with topics in Bronchoalveolar lavage and Intestinal mucosa. His work carried out in the field of Mucin brings together such families of science as Molecular biology and Gene expression, In situ hybridization.
He combines subjects such as Liver injury and Dysbiosis with his study of Alcoholic liver disease. His Liver disease research includes themes of Chronic liver disease, Cirrhosis and Steatohepatitis. The concepts of his Internal medicine study are interwoven with issues in Virus, Hepatitis C virus, Surgery and Alpha interferon.
Samuel B. Ho focuses on Internal medicine, Mucin, Immunology, Gastroenterology and Hepatitis C. His study looks at the relationship between Internal medicine and topics such as Surgery, which overlap with Colonoscopy. His work deals with themes such as Immunohistochemistry, Molecular biology and Epithelium, which intersect with Mucin.
His Immunology research includes elements of Liver disease, Alcoholic liver disease and Helicobacter pylori. His Liver disease research incorporates themes from Cirrhosis, Steatohepatitis and Dysbiosis. His Hepatitis C study deals with Depression intersecting with Psychological intervention and Physical therapy.
Samuel B. Ho focuses on Internal medicine, Liver disease, Alcoholic liver disease, Gastroenterology and Cirrhosis. He regularly ties together related areas like Endocrinology in his Internal medicine studies. His study looks at the intersection of Liver disease and topics like Alcoholic hepatitis with Antibiotics, Cholesterol 7 alpha-hydroxylase, Chenodeoxycholic acid and Cholestasis.
He has included themes like Liver injury, Immunology, Chronic liver disease, Steatohepatitis and Dysbiosis in his Alcoholic liver disease study. Immunology and Intestinal mucosa are frequently intertwined in his study. His Dysbiosis research incorporates elements of Saturated fatty acid, Molecular biology and Intestinal permeability.
His main research concerns Liver disease, Alcoholic liver disease, Internal medicine, Immunology and Dysbiosis. His Liver disease study combines topics in areas such as Chronic liver disease, Cirrhosis, Steatohepatitis and Alcoholic hepatitis. His biological study spans a wide range of topics, including Steatosis, Liver injury, Pathology, Andrology and Fatty liver.
His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Interleukin 21 and Alcohol use disorder. His biological study deals with issues like Intestinal mucosa, which deal with fields such as Apoptosis and Epithelial Damage. Samuel B. Ho interconnects Intestinal permeability and Cecum in the investigation of issues within Dysbiosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and Progress
Young S. Kim;Young S. Kim;Samuel B. Ho.
Current Gastroenterology Reports (2010)
Heterogeneity of Mucin Gene Expression in Normal and Neoplastic Tissues
Samuel B. Ho;Gloria A. Niehans;Carolyn Lyftogt;Pei Sha Yan.
Cancer Research (1993)
Neuropsychiatric Symptoms Associated With Hepatitis C and Interferon Alpha: A Review
Eric Dieperink;Mark Willenbring;Samuel B. Ho.
American Journal of Psychiatry (2000)
Human gastric mucin. Identification of a unique species by expression cloning.
Neil W. Toribara;Anthony M. Roberton;Samuel B. Ho;Wen Lin Kuo.
Journal of Biological Chemistry (1993)
A gp130-Src-YAP Module Links Inflammation to Epithelial Regeneration
Koji Taniguchi;Koji Taniguchi;Koji Taniguchi;Li Wha Wu;Li Wha Wu;Sergei I. Grivennikov;Sergei I. Grivennikov;Petrus R. De Jong.
Nature (2015)
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
Ying-Nan P. Chen;Matthew J. LaMarche;Ho Man Chan;Peter Fekkes.
Nature (2016)
Mucin Gene Expression in Normal, Preneoplastic, and Neoplastic Human Gastric Epithelium
Samuel B. Ho;Laurie L. Shekels;Neil W. Toribara;Young S. Kim.
Cancer Research (1995)
Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trial
Ira M. Jacobson;Robert S. Brown;Bradley Freilich;Nezam Afdhal.
Hepatology (2007)
A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion.
Ui-Angela Temann;Bhagi Prasad;Marianne W. Gallup;Carol Basbaum.
American Journal of Respiratory Cell and Molecular Biology (1997)
Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer
Sae-Kyung Chang;Austin F. Dohrman;Carol B. Basbaum;Samuel B. Ho.
Gastroenterology (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of California, San Diego
University of Minnesota
Stanford University
Chinese Academy of Sciences
University of Nebraska Medical Center
University of California, San Francisco
J. Craig Venter Institute
Harvard University
Yale University
GlaxoSmithKline (United States)
University of Southampton
Queen Mary University of London
Argonne National Laboratory
Spanish National Research Council
Georgia State University
Stellenbosch University
University of Aveiro
Johns Hopkins University Applied Physics Laboratory
Pacific Northwest National Laboratory
Eötvös Loránd University
University of Pittsburgh
University of Richmond
University of Kentucky
New Mexico State University
Fermilab
University of Minnesota